{"entity":{"type":"insider","cik":"0001406049","url":"/insider/0001406049","json_url":"/insider/0001406049.json","name":"Kazmi Syed","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2009-12-24","last":"2011-03-01","span_basis":"filed_date"},"name_variants":[{"name":"Kazmi Syed","source":"filing","n_filings":2,"first_seen":"2009-12-24","last_seen":"2011-03-01"}],"transactions":[{"id":8836881,"accession":"0000886163-11-000023","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000886163-11-000023","line_url":"/filing/0000886163-11-000023#line-4","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001406049","owner_name":"Kazmi Syed","owner_url":"/insider/0001406049","role":"Officer (VP, Bus. Dev. & Strategic Plan)","officer_title":"VP, Bus. Dev. & Strategic Plan","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":866.0,"shares_display":"866","price_per_share":10.68,"price_display":"10.68","price_state":"stated","total_value":9248.88,"total_display":"9,248.88","shares_owned_after":14230.0,"shares_owned_after_display":"14,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-01","scope":"insider"},{"id":8836880,"accession":"0000886163-11-000023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000886163-11-000023","line_url":"/filing/0000886163-11-000023#line-3","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001406049","owner_name":"Kazmi Syed","owner_url":"/insider/0001406049","role":"Officer (VP, Bus. Dev. & Strategic Plan)","officer_title":"VP, Bus. Dev. & Strategic Plan","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":10.71,"price_display":"10.71","price_state":"stated","total_value":1071.0,"total_display":"1,071.00","shares_owned_after":15196.0,"shares_owned_after_display":"15,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-01","scope":"insider"},{"id":8836878,"accession":"0000886163-11-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-11-000023","line_url":"/filing/0000886163-11-000023#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001406049","owner_name":"Kazmi Syed","owner_url":"/insider/0001406049","role":"Officer (VP, Bus. Dev. & Strategic Plan)","officer_title":"VP, Bus. Dev. & Strategic Plan","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":10.7,"price_display":"10.70","price_state":"stated","total_value":1070.0,"total_display":"1,070.00","shares_owned_after":15296.0,"shares_owned_after_display":"15,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-01","scope":"insider"},{"id":8836876,"accession":"0000886163-11-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-11-000023","line_url":"/filing/0000886163-11-000023#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001406049","owner_name":"Kazmi Syed","owner_url":"/insider/0001406049","role":"Officer (VP, Bus. Dev. & Strategic Plan)","officer_title":"VP, Bus. Dev. & Strategic Plan","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":10.69,"price_display":"10.69","price_state":"stated","total_value":1069.0,"total_display":"1,069.00","shares_owned_after":15096.0,"shares_owned_after_display":"15,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-01","scope":"insider"},{"id":5603529,"accession":"0000886163-09-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-09-000028","line_url":"/filing/0000886163-09-000028#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001406049","owner_name":"Kazmi Syed","owner_url":"/insider/0001406049","role":"Officer (VP, Bus. Dev. & Strategic Plan)","officer_title":"VP, Bus. Dev. & Strategic Plan","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":4300.0,"total_display":"4,300.00","shares_owned_after":57710.0,"shares_owned_after_display":"57,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-24","filed_date":"2009-12-24","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Officer (VP, Bus. Dev. & Strategic Plan)","n_filings":2,"first_seen":"2009-12-24","last_seen":"2011-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001406049","retrieved_at":"2026-08-21T11:22:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}